FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:2035-2041 November 20, 2003 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.

A 22-year-old woman who wants to become pregnant has had no menses since she discontinued the use of an oral contraceptive one year ago, and recently, galactorrhea developed. She takes no medications and has had no headaches, visual loss, dyspareunia, or decreased libido. Physical examination shows no abnormalities, except for the bilateral breast discharge. A test for serum human chorionic gonadotropin is . . . [Full Text of this Article]

The Clinical Problem

Clinical Presentation

Causes of Hyperprolactinemia

Strategies and Evidence

Diagnostic Studies

Therapy

            Microadenomas

            Macroadenomas

            Hypogonadism

Areas of Uncertainty

Guidelines

Conclusions and Recommendations

Source Information

From the Department of Internal Medicine, University of Iowa, Iowa City.

Address reprint requests to Dr. Schlechte at the Department of Internal Medicine, 157 MRF, University of Iowa Hospitals and Clinics, 200 Hawkins Dr., Iowa City, IA 52242, or at janet-schlechte@uiowa.edu.

Related Letters:

Prolactinomas
Friedman T. C., Couldwell W. T., Weiss M. H., Laws E. R. Jr., Hortin G. L., Colao A., Lombardi G., Schlechte J.
Extract | Full Text | PDF  
N Engl J Med 2004; 350:1054-1057, Mar 4, 2004. Correspondence

This article has been cited by other articles:

• Lancellotti, P., Livadariu, E., Markov, M., Daly, A. F, Burlacu, M.-C., Betea, D., Pierard, L., Beckers, A. (2008). Cabergoline and the risk of valvular lesions in endocrine disease.. Eur J Endocrinol 159: 1-5 [Abstract] [Full Text]  
• Holt, R. I. (2008). Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists. J Psychopharmacol 22: 28-37 [Abstract]  
• Schlechte, J. A. (2007). Long-Term Management of Prolactinomas. J. Clin. Endocrinol. Metab. 92: 2861-2865 [Abstract] [Full Text]  
• Imran, S. A., Ur, E., Clarke, D. B. (2007). Managing prolactin-secreting adenomas during pregnancy. cfp 53: 653-658 [Abstract] [Full Text]  
• Dekkers, O M, Hammer, S, de Keizer, R J W, Roelfsema, F, Schutte, P J, Smit, J W A, Romijn, J A, Pereira, A M (2007). The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol 156: 217-224 [Abstract] [Full Text]  
• Levine, S. B. (2005). A Reintroduction to Clinical Sexuality. Focus 3: 526-531 [Abstract] [Full Text]  
• Nemergut, E. C., Dumont, A. S., Barry, U. T., Laws, E. R. (2005). Perioperative Management of Patients Undergoing Transsphenoidal Pituitary Surgery. Anesth. Analg. 101: 1170-1181 [Abstract] [Full Text]  
• Marx, S. J., Simonds, W. F. (2005). Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes. Endocr. Rev. 26: 615-661 [Abstract] [Full Text]  
• Friedman, T. C., Couldwell, W. T., Weiss, M. H., Laws, E. R. Jr., Hortin, G. L., Colao, A., Lombardi, G., Schlechte, J. (2004). Prolactinomas. NEJM 350: 1054-1057 [Full Text]